Academic Work

• ORCID
• Google scholar
• ResearchGate
• Scopus

Sustainable Development Goals

Research interests

• Development of neuroprotective drugs
• Toxicity of metals studies
• Experimental models of neurological diseases
• Development of biopolymers
• Development of cannabinoids

Profile

Doctor Luis Camilo Ríos Castañeda graduated as a Chemist, with honors, from the Faculty of Chemistry of the Universidad Nacional Autónoma de México (UNAM). In 1994, he obtained his Ph.D. in Sciences at CINVESTAV of the Instituto Politécnico Nacional (IPN), specializing in Pharmacology. At the invitation of the Newton Fund of the United Kingdom, he carried out two stays in London and Oxford through the Leaders in Innovation Fellowships program.

He has been a Professor in the QFB career and in the Master's and Doctorate Program in Pharmaceutical Sciences at the Universidad Autónoma Metropolitana (UAM) since 1989.

Dr. Ríos' research work is reflected in more than 300 articles published in international peer-reviewed scientific journals, with more than 7900 citations to his work, with an H index of 52, according to Scopus. He has been a National Researcher Level 3, of the National System of Researchers, since 2004.

He has been a tutor or co-tutor of 30 Ph.D. graduates, 35 Master of Science graduates, and about 50 undergraduate students at UNAM, UAM, CINVESTAV, IPN, UAEM, and UAZ.

He has been a member of the editorial board of the journals: Archivos de Neurociencias (1994- to date), Toxicology Letters (1996-1999), Revista Mexicana de Ciencias Farmacéuticas (2008-2015), Co-Editor of the Revista de Investigación Clínica (2009-2012) and is a Numerary Academician of the National Academy of Medicine of Mexico, Full Academician of the National Academy of Pharmaceutical Sciences and Corresponding Academician of the Royal Academy of Pharmacy of Spain.

Dr. Ríos has been the winner of several national and international research awards, such as: The Gen Award, the Glaxo-Wellcome Award, the Western Pharmacology Society Award, the National Chemistry Award, "Andrés Manuel del Río" 2011, the Award of Merit in Neurology and Neurosurgery "Dr. Manuel Velasco Suárez" 2013, presented by Mr. President of Mexico, the Hidalgo Award for Science, Technology and Innovation 2014, and one of the Awards of the Ibero-American Academy of Pharmacy in 2020.

Information provided by the academic staff

Research interests

• Development of neuroprotective drugs
• Toxicity of metals studies
• Experimental models of neurological diseases
• Development of biopolymers
• Development of cannabinoids

Academic Work

On the following pages you can consult the research work:

• Google scholar

See publications

• ResearchGate

See publications

• Scopus

See publications

• ORCID

See publications

Some examples of publications

Select the bibliographic reference to consult each publication:

Open Access	References	UN SDGs
OA	Arteaga-Silva, M., Vigueras-Villaseñor, R.M., Guillen-Herrera, G. and 6 more (...) (2025).Perinatal exposure to lead alters male reproductive behaviour and immunoreactivity of androgen and oestrogen receptors in the brain. International Journal of Experimental Pathology,106(1)	\| 3\| 6 \|
	Lamas-Aguilar, R., Diaz-Ruiz, A., Navarro, L. and 4 more (...) (2025).Corrigendum to: Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review. Current Neuropharmacology,23(14)
OA	Martínez-Rodríguez, E.J., Barón-Flores, V., Ramirez-Bermudez, J. and 4 more (...) (2025).Plasma Glutathione Concentrations Are Associated with Leukocyte and Neutrophils’ Counts in Clozapine-Treated Patients. Pharmaceuticals,18(9)
OA	Ríos, C., Salgado-Ceballos, H., Grijalva, I. and 15 more (...) (2025).Demonstration of therapeutic effect of plasma-synthesized polypyrrole/iodine biopolymer in rhesus monkey with complete spinal cord section. Journal of Materials Science: Materials in Medicine,36(1)
OA	Ruiz-Diaz, D., Manjarrez-Marmolejo, J., Diaz-Ruiz, A. and 7 more (...) (2024).Development and Characterization of Electrodes Coated with Plasma-Synthesized Polypyrrole Doped with Iodine, Implanted in the Rat Brain Subthalamic Nucleus. Polymers,16(6)
OA	Mata-Bermudez, A., Diaz-Ruiz, A., Silva-García, L.R. and 7 more (...) (2024).Mucuna pruriens, a Possible Treatment for Depressive Disorders. Neurology International,16(6) 1509-1527	\| 3 \|
OA	Jardón-Guadarrama, G., Manríquez-Ramírez, M.E., Rodríguez-Pérez, C.E. and 5 more (...) (2024).TiO2-ZnPc nanoparticles functionalized with folic acid as a target photosensitizer for photodynamic therapy against glioblastoma cells. Journal of Materials Science: Materials in Medicine,35(1)	\| 3 \|
	Verduzco-Mendoza, A., Mota-Rojas, D., Olmos-Hernández, A. and 12 more (...) (2024).Changes in Noradrenergic Synthesis and Dopamine Beta-Hydroxylase Activity in Response to Oxidative Stress after Iron-induced Brain Injury. Neurochemical Research,49(11) 3043-3059
OA	Mata-Bermudez, A., Trejo-Chávez, R., Martínez-Vargas, M. and 7 more (...) (2024).Effect of Mucuna pruriens seed extract on depression-like behavior derived from mild traumatic brain injury in rats. BioMedicine (Taiwan),14(3) 23-30
OA	Aguila-Rosas, J., García-Martínez, B.A., Ríos, C. and 6 more (...) (2024).Copper release by MOF-74(Cu): a novel pharmacological alternative to diseases with deficiency of a vital oligoelement. RSC Advances,14(2) 855-862
OA	Mata-Bermudez, A., Trejo-Chávez, R., Martínez-Vargas, M. and 5 more (...) (2024).Dysregulation of the dopaminergic system secondary to traumatic brain injury: implications for mood and anxiety disorders. Frontiers in Neuroscience,18
OA	Islas-Cortez, M., Ríos, C., Manzanares, J. and 2 more (...) (2024).Isobolographic Analysis of the Cytoprotective Effect of Dapsone and Cannabidiol Alone or Combination upon Oxygen–Glucose Deprivation/Reoxygenation Model in SH-SY5Y Cells. Antioxidants,13(6)
	Arteaga-Silva, M., Limón-Morales, O., Bonilla-Jaime, H. and 6 more (...) (2023).Effects of postnatal exposure to cadmium on male sexual incentive motivation and copulatory behavior: Estrogen and androgen receptors expression in adult brain rat. Reproductive Toxicology,120
OA	Calderón-Estrella, F., Franco-Bourland, R.E., Rios, C. and 5 more (...) (2023).Early treatment with dapsone after spinal cord injury in rats decreases the inflammatory response and promotes long-term functional recovery. Heliyon,9(4)
OA	Mayén-Lobo, Y.G., Alcaraz-Zubeldia, M., Dávila-Ortiz de Montellano, D.J. and 8 more (...) (2023).Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disorders. Brazilian Journal of Psychiatry,45(2) 117-126
OA	Coyoy-Salgado, A., Orozco-Barrios, C., Sánchez-Torres, S. and 12 more (...) (2023).Gene expression and locomotor recovery in adult rats with spinal cord injury and plasma-synthesized polypyrrole/iodine application combined with a mixed rehabilitation scheme. Frontiers in Neurology,14
	Avila-Luna, A., Gálvez-Rosas, A., Aguirre-Pérez, A. and 5 more (...) (2023).Chronic H3R activation reduces L-Dopa-induced dyskinesia, normalizes cortical GABA and glutamate levels, and increases striatal dopamine D1R mRNA expression in 6-hydroxydopamine-lesioned male rats. Psychopharmacology,240(6) 1221-1234
	Ríos, C., Aguirre-Aranda, I., Avendaño-Estrada, A. and 7 more (...) (2023).Characterization of the anticonvulsant effect of dapsone on metabolic activity assessed by [18F]FDG -PET after kainic acid-induced status epilepticus in rats. Brain Research,1803
OA	Hernández-Cerón, M., Chavarria, V., Ríos, C. and 4 more (...) (2023).Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis. Brain Sciences,13(6)	\| 3 \|
	Baron-Flores, V., Diaz-Ruiz, A., Manzanares, J. and 5 more (...) (2022).Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats. Neuroscience Letters,788
OA	Farías, P., Hernández-Bonilla, D., Moreno-Macías, H. and 5 more (...) (2022).Prenatal Co-Exposure to Manganese, Mercury, and Lead, and Neurodevelopment in Children during the First Year of Life. International Journal of Environmental Research and Public Health,19(20)
OA	Morales-Guadarrama, A., Salgado-Ceballos, H., Grijalva, I. and 12 more (...) (2022).Evolution of Spinal Cord Transection of Rhesus Monkey Implanted with Polymer Synthesized by Plasma Evaluated by Diffusion Tensor Imaging. Polymers,14(5)
	Cortez-Lugo, M., Hernández-Bonilla, D., Rodríguez-Agudelo, Y. and 7 more (...) (2022).Neurocognitive function in adult residents of a mining district in Mexico after reducing manganese exposure: Follow-up after 11 years. Science of the Total Environment,848
OA	Diaz-Ruiz, A., Nader-Kawachi, J., Calderón-Estrella, F. and 3 more (...) (2022).Dapsone, More than an Effective Neuro and Cytoprotective Drug. Current Neuropharmacology,20(1) 194-210	\| 3 \|
	Anaya-Ramos, L., Díaz-Ruíz, A., Ríos, C. and 6 more (...) (2021).The acute systemic toxicity of thallium in rats produces oxidative stress: attenuation by metallothionein and Prussian blue. BioMetals,34(6) 1295-1311	\| 3\| 6 \|
	García-Martínez, B.A., Montes, S., Tristán-López, L. and 4 more (...) (2021).Copper biodistribution after acute systemic administration of copper gluconate to rats. BioMetals,34(3) 687-700
	Islas-Cortez, M., Rios, C., Rubio-Osornio, M. and 5 more (...) (2021).Characterization of the antiapoptotic effect of copper sulfate on striatal and midbrain damage induced by MPP+ in rats. NeuroToxicology,8218-25
	Ortega-Vázquez, A., Mayen-Lobo, Y.G., Dávila-Ortiz de Montellano, D.J. and 5 more (...) (2021).Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis. Drug Development Research,82(5) 685-694
	Mata-Bermudez, A., Ríos, C., Burelo, M. and 6 more (...) (2021).Amantadine prevented hypersensitivity and decreased oxidative stress by NMDA receptor antagonism after spinal cord injury in rats. European Journal of Pain (United Kingdom),25(8) 1839-1851
	Avendaño-Estrada, A., Rios, C., Aguirre-Aranda, I. and 7 more (...) (2021).Characterization of metabolic activity induced by kainic acid in adult rat whole brain at the early stage: A 18FDG-PET study. Brain Research,1769
OA	Verónica, B.-F., Martínez-Rodríguez, E., Hernández-López, D. and 4 more (...) (2021).Anticonvulsant and antidepressant effect of the ethanolic extract of Annona reticulata leaves in rat. Archivos de Neurociencias,26(3) 17-23	\| 3 \|
	Hernández-Rodríguez, J., López, A.L., Montes, S. and 7 more (...) (2021).Delay in puberty indices of Wistar rats caused by Cadmium. Focus on the redox system in reproductive organs. Reproductive Toxicology,9971-79	\| 3 \|
	Sánchez-Torres, S., Díaz-Ruíz, A., Ríos, C. and 15 more (...) (2020).Recovery of motor function after traumatic spinal cord injury by using plasma-synthesized polypyrrole/iodine application in combination with a mixed rehabilitation scheme. Journal of Materials Science: Materials in Medicine,31(7)

Courses taught by the professor in recent trimesters

*Courses are conducted in spanish

Num.	Trim.	Course Name	Level
1	25O	Los Fármacos como Modificadores de Funciones Biológicas	Licenciatura
2	25O	Seminario de Investigación II	Posgrado
3	25O	Seminario de Avances de Investigación VII	Posgrado
4	25O	Trabajo de Investigación IX	Posgrado
5	25O	Trabajo de Redacción de Tesis III	Posgrado
6	25P	Los Fármacos como Modificadores de Funciones Biológicas	Licenciatura
7	25P	Proyecto de Investigación III	Posgrado
8	25P	Seminario de Investigación I	Posgrado
9	25P	Trabajo de Investigación VIII	Posgrado
10	25P	Trabajo de Redacción de Tesis III	Posgrado
11	25P	Trabajo de Redacción de Tesis II	Posgrado
12	25I	Proyecto de Investigación II	Posgrado
13	25I	Planeación y Diseño de la Investigación en Ciencias Farmacéuticas	Posgrado
14	25I	Trabajo de Investigación VII	Posgrado
15	25I	Trabajo de Redacción de Tesis II	Posgrado
16	25I	Trabajo de Redacción de Tesis I	Posgrado
17	25I	Los Fármacos como Modificadores de Funciones Biológicas	Licenciatura
18	24O	Los Fármacos como Modificadores de Funciones Biológicas	Licenciatura
19	24O	Proyecto de Investigación I	Posgrado
20	24O	Seminario de Avances de Investigación VI	Posgrado
21	24O	Trabajo de Investigación VI	Posgrado
22	24O	Trabajo de Redacción de Tesis I	Posgrado
23	24O	Trabajo de Investigación IX	Posgrado
24	24O	Seminario VII	Posgrado
25	24P	Los Fármacos como Modificadores de Funciones Biológicas	Licenciatura
26	24P	Proyecto de Investigación III	Posgrado
27	24P	Seminario de Avances de Investigación V	Posgrado
28	24P	Seminario de Avances de Investigación VII	Posgrado
29	24P	Trabajo de Investigación V	Posgrado
30	24P	Trabajo de Investigación IX	Posgrado
31	24P	Trabajo de Investigación VIII	Posgrado
32	24I	Trabajo de Investigación VII	Posgrado
33	24I	Proyecto de Investigación II	Posgrado
34	24I	Seminario de Avances de Investigación IV	Posgrado
35	24I	Trabajo de Investigación IV	Posgrado
36	24I	Trabajo de Investigación VIII	Posgrado
37	23O	Proyecto de Investigación I	Posgrado
38	23O	Proyecto de Investigación III	Posgrado
39	23O	Seminario de Investigación II	Posgrado
40	23O	Seminario de Avances de Investigación III	Posgrado
41	23O	Seminario de Avances de Investigación VII	Posgrado
42	23O	Trabajo de Investigación III	Posgrado
43	23O	Trabajo de Investigación VII	Posgrado
44	23O	Seminario VI	Posgrado
45	23O	Trabajo de Investigación VI	Posgrado
46	23P	Seminario V	Posgrado
47	23P	Trabajo de Investigación V	Posgrado
48	23P	Trabajo de Redacción de Tesis III	Posgrado
49	23P	Proyecto de Investigación II	Posgrado
50	23P	Proyecto de Investigación III	Posgrado
51	23P	Proyecto de Investigación III	Posgrado
52	23P	Seminario de Investigación I	Posgrado
53	23P	Seminario de Avances de Investigación II	Posgrado
54	23P	Seminario de Avances de Investigación VI	Posgrado
55	23P	Trabajo de Investigación II	Posgrado
56	23P	Trabajo de Investigación VI	Posgrado
57	23I	Proyecto de Investigación I	Posgrado
58	23I	Proyecto de Investigación II	Posgrado
59	23I	Proyecto de Investigación II	Posgrado
60	23I	Farmacia Clínica y Métodos en la Investigación Farmacéutica	Posgrado

Information provided by the Dirección de Sistemas Escolares

Return to list